Regulatory modifiers of coding variant penetrance via haplotype epistasis in human populations and diseases
Regulatory modifiers of coding variant penetrance via haplotype epistasis in human populations and diseases
批准号:
9926898
负责人:
Tuuli Lappalainen
金额:
$37.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-01 至 2022-04-30
关键词:
AffectAllelesClinicalCodeCollectionDataData SetDiseaseEvolutionExonsFamilyFutureGene ExpressionGene Expression RegulationGene FrequencyGenesGeneticGenetic DiseasesGenetic EpistasisGenetic ModelsGenetic RiskGenetic VariationGenetic studyGenomeGenotype-Tissue Expression ProjectHaplotypesHeritabilityHumanHuman Cell LineHuman GeneticsIndividualLightLinkage DisequilibriumMalignant NeoplasmsMapsMendelian disorderMethodsModelingMutationNatural SelectionsOutcomePatternPenetrancePhasePhenotypePopulationPopulation GeneticsPrevalenceProxyRET geneRNA SplicingRiskRoleSeveritiesShapesSignal TransductionTissuesTumor Suppressor GenesVariantWorkautism spectrum disorderbasebiobankdisorder riskdriver mutationexomeexome sequencingfunctional genomicsgene functiongenetic analysisgenetic architecturegenetic variantgenome editinggenome sequencinggenome wide association studyhuman diseaseimprovedinsightnovelrare varianttraittranscriptome sequencingwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Variable penetrance is a phenomenon where the severity of the effect of a genetic variant differs among
individuals who carry it. We propose to study a specific type of modified penetrance caused by genetic
interaction or epistasis in humans, where a regulatory variant in cis modifies the penetrance of coding variants
of the target gene. We call this phenomenon haplotype epistasis. We will study this phenomenon using genetic
data of the general human population and of diseases with different genetic architectures. First, we will study
signals of purifying selection against specific haplotype combinations as a proxy of phenotypically relevant
epistatic effects. This will shed light on the modes and prevalence of haplotype epistasis, and the role of
epistatic selection in shaping the spectrum of genetic variation in humans. Second, haplotype epistasis has
been shown to affect genetic disease risk in some specific examples, but this mechanism is rarely considered
in genetic studies that typically analyze genetic variants one-by-one. We aim to characterize haplotype
epistasis as a potentially important phenomenon in rare variants contributing to autism risk, common variants
predisposing to diverse traits mapped by genome-wide association studies, and germline modifiers of somatic
cancer driver mutations. Furthermore, we will validate 5-10 examples of epistasis by genome editing of human
cell lines, followed by cellular phenotyping. In summary, our study integrates many domains in human genetics
that are usually studied in isolation. It is the first systematic characterization of haplotype epistasis and has
potential to bring forward an important paradigm of epistatic functional effects of genetic variants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiscale genome engineering to map cis-regulatory variants in human and mouse
-
批准号:10737026
-
项目类别:
-
资助金额:$113.33万
-
财政年份:2023
-
负责人:Tuuli Lappalainen
-
依托单位:
海外基金